TY - GEN
T1 - Recurrent Pregnancy Loss
T2 - immunological risk factors and immunomodulatory treatments
AU - Nørgaard-Pedersen, Caroline
PY - 2023
Y1 - 2023
N2 - This PhD thesis aimed to explore the role of the immune system in recurrent pregnancy loss (RPL) pathogenesis and the effect of immunomodulatory treatments. The thesis contains four original research articles investigating the association between specific immune biomarkers and RPL and one randomized controlled trial protocol for an ongoing placebo-controlled trial that aims to examine the clinical and immunomodulatory effects of intravenous immunoglobulin combined with low-dose oral glucocorticoid treatment as well as the presence of immune biomarkers among women with RPL undergoing artificial reproductive technology treatment.The introduction includes a description of the epidemiology and etiology of RPL. Furthermore, a brief description of the current knowledge of the immunological role in normal pregnancy and the immune system aberrations found in patients with RPL is given. Finally, treatments recommended for patients with RPL and immunomodulatory treatments under investigation are presented.
AB - This PhD thesis aimed to explore the role of the immune system in recurrent pregnancy loss (RPL) pathogenesis and the effect of immunomodulatory treatments. The thesis contains four original research articles investigating the association between specific immune biomarkers and RPL and one randomized controlled trial protocol for an ongoing placebo-controlled trial that aims to examine the clinical and immunomodulatory effects of intravenous immunoglobulin combined with low-dose oral glucocorticoid treatment as well as the presence of immune biomarkers among women with RPL undergoing artificial reproductive technology treatment.The introduction includes a description of the epidemiology and etiology of RPL. Furthermore, a brief description of the current knowledge of the immunological role in normal pregnancy and the immune system aberrations found in patients with RPL is given. Finally, treatments recommended for patients with RPL and immunomodulatory treatments under investigation are presented.
U2 - 10.54337/aau620097234
DO - 10.54337/aau620097234
M3 - PhD thesis
T3 - Aalborg Universitet. Det Sundhedsvidenskabelige Fakultet. Ph.D.-Serien
PB - Aalborg Universitetsforlag
ER -